Leaflet MYDERISON 150mg film-coated tablets

Product code:
W68584001
Quantity:
20
Indicated for:
spasticity; muscle spasms
Route of administration:
oral
Substance:
tolperisone (muscle relaxant)
ATC
M03BX04 — Musculo-skeletal system | Muscle relaxants | Muscle relaxants, centrally acting agents | Other centrally acting agents
Tolperisone is a medication used to treat muscle spasms and muscle hypertonicity associated with neurological or musculoskeletal conditions, such as multiple sclerosis, strokes, spinal cord injuries, or back pain. It is a centrally acting muscle relaxant that reduces excessive muscle tone without causing significant sedation.

Tolperisone works by inhibiting the transmission of nerve impulses in the spinal cord and improving local blood circulation, which helps reduce muscle spasms and associated pain. The medication is taken orally, usually 2-3 times per day, as directed by a doctor.

Common side effects include nausea, vomiting, abdominal pain, dizziness, and allergic reactions such as skin rashes or itching. In rare cases, severe hypersensitivity reactions may occur. Tolperisone is contraindicated in patients with myasthenia gravis (a neuromuscular disease) and should be used with caution in pregnant or breastfeeding women.

General data about MYDERISON 150mg

Substance:
tolperisone
Date of latest medicines list:
01-04-2022
Product code:
W68584001
Concentration:
150mg
Pharmaceutical form:
film-coated tablets
Quantity:
20
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
MEDITOP PHARMACEUTICAL LTD - UNGARIA
Holder:
MEDITOP PHARMACEUTICAL LTD. - UNGARIA
Number:
11571/2019/01
Shelf life:
5 years

Pharmaceutical forms available for tolperisone

Concentrations available for tolperisone

  • 100mg/ml
  • 150mg
  • 50mg